VDAC2 loss elicits tumour destruction and inflammation for cancer therapy
Sujing Yuan(St. Jude Children's Research Hospital), Hongbo Chi(St. Jude Children's Research Hospital), Xiaoxi Meng(University of Nebraska–Lincoln), Anil KC(St. Jude Children's Research Hospital), Stephen Gottschalk(St. Jude Children's Research Hospital), Cliff Guy(St. Jude Children's Research Hospital), Sherri L. Rankin(St. Jude Children's Research Hospital), Xiaoyang Yang(St. Jude Children's Research Hospital), Hao Shi(St. Jude Children's Research Hospital), Xiang Sun(St. Jude Children's Research Hospital), Gustavo Palacios(St. Jude Children's Research Hospital), Haoran Hu(St. Jude Children's Research Hospital), Renqiang Sun(Shanghai Medical College of Fudan University), Peipei Zhou(St. Jude Children's Research Hospital), Nicole M. Chapman(St. Jude Children's Research Hospital)
Cited by 66
Related Papers
HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
|The Journal of Experimental Medicine|2011|1.8k
Regulation and function of mTOR signalling in T cell fate decisions
|Nature reviews. Immunology|2012|996